Jane Street
TARS icon

Jane Street’s Tarsus Pharmaceuticals TARS Stock Holding History

Jane Street’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-266,600
Closed -$14.8M – 10580
2024
Q4 		$14.8M Buy
+266,600
New +$12.1M ﹤0.01% 1532
2024
Q2 		– Sell
-55,300
Closed -$2.01M – 10171
2024
Q1 		$2.01M Buy
+55,300
New +$1.63M ﹤0.01% 4116

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street's TARS Position: Q1 2026 in Review

Jane Street sold out of Tarsus Pharmaceuticals (TARS) in Q1 2026, closing a stake of 20,486 shares — an estimated $1.43M sold.

Jane Street first reported a position in TARS in Q3 2023 and held it in 9 quarters. The position peaked at $3.6M in Q3 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Jane Street reported no remaining Tarsus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 20,486 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $1.43M.
  • Jane Street first reported a position in Tarsus Pharmaceuticals in Q3 2023 and held it in 9 quarters.
  • Jane Street's Tarsus Pharmaceuticals position peaked at $3.6M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.